Intensity-Modulated Radiation Therapy (IMRT) alone (for early stage)
Treatment for Nasopharynx Cancer
Typical Dosage: 66-70 Gy in 30-35 fractions.
Effectiveness
80%
Safety Score
30%
Clinical Trials
1
Participants
18K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
30
DangerousModerateSafe
Treatment Details
Dosage Range
66-70 Gy in 30-35 fractions.
Time to Effect
During and immediately after treatment (weeks to months)
Treatment Duration
6-7 weeks
Evidence Quality
HIGHConfidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$20,000
Side Effect Mgmt:$10,000
Total Annual:$30,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTQALYs Gained
2
Outcome-Based Costs
Cost per Responder
$35,294
Cost per Remission
$37,500
Prescription Access Economics
Risk Assessment
Requires Monitoring
YesNeeds lab work/checkups
Intensity-Modulated Radiation Therapy (IMRT) alone (for early stage) Outcomes
for Nasopharynx Cancer
Efficacy Outcomes
Overall Effectiveness
+80%
Response Rate
+85%
Remission Rate
+80%
Common Side Effects
Xerostomia
+80%
Mucositis
+70%
Dermatitis
+75%
Fatigue
+70%
Dysphagia
+50%
Cranial nerve deficits
+10%
Sources:
Active Clinical Trials
1 active trial recruiting for Intensity-Modulated Radiation Therapy (IMRT) alone (for early stage) in Nasopharynx Cancer
Optimization of Cervical Nodal CTV for Early and Medium Stage NPC
NCT05145660ACTIVE NOT RECRUITINGPHASE3
414 participants
INTERVENTIONAL
Beijing, China
Started: Sep 1, 2022